Intellia Therapeutics (NTLA) Enterprise Value Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.36% |
| Dec 31, 2025 | 25.21% |
| Sep 30, 2025 | 22.35% |
| Jun 30, 2025 | 33.49% |
| Mar 31, 2025 | 36.34% |
| Dec 31, 2024 | 34.06% |
| Sep 30, 2024 | 23.01% |
| Jun 30, 2024 | 23.90% |
| Mar 31, 2024 | 15.24% |
| Dec 31, 2023 | 23.51% |
| Sep 30, 2023 | -3.21% |
| Jun 30, 2023 | -3.87% |
| Mar 31, 2023 | -9.15% |
| Dec 31, 2022 | -58.85% |
| Sep 30, 2022 | -3.75% |
| Jun 30, 2022 | -65.26% |
| Mar 31, 2022 | -46.43% |
| Dec 31, 2021 | -25.68% |
| Sep 30, 2021 | -95.68% |
| Jun 30, 2021 | -21.11% |
| Mar 31, 2021 | -133.38% |
| Dec 31, 2020 | -113.56% |
| Sep 30, 2020 | -42.68% |
| Jun 30, 2020 | -61.12% |
| Mar 31, 2020 | -431.37% |
| Dec 31, 2019 | 10.93% |
| Sep 30, 2019 | 2.50% |
| Jun 30, 2019 | 11.27% |
| Mar 31, 2019 | 85.63% |
| Dec 31, 2018 | 7.81% |
| Sep 30, 2018 | -31.94% |
| Jun 30, 2018 | -26.75% |
| Mar 31, 2018 | -27.27% |
| Dec 31, 2017 | -24.76% |
| Sep 30, 2017 | 23.52% |
| Jun 30, 2017 | 19.83% |
| Mar 31, 2017 | -301.22% |
| Dec 31, 2016 | -260.17% |
| Sep 30, 2016 | -251.79% |
| Jun 30, 2016 | -1,421.31% |
| Mar 31, 2016 | -247.38% |